PLUS1
87.06
-1.33 (-1.5%)
-1.33 (-1.5%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 8,055,542 |
|
|||||
| News | (1) | ||||||
| Day High | 88.01 | Low High |
|||||
| Day Low | 87.23 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.33 | -1.5% | 87.06 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 87.76 | 87.23 | 88.01 | 87.44 | 88.39 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 82,627 | 8,055,542 | $ 87.69 | $ 706,418,052 | - | 71.50 - 95.72 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:44:51 | 3 | $ 87.06 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 220.55B | 2.53B | 2.53B | $ 50.16B | $ 13.77B | 5.14 | 13.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.64 | 3.12% | 09/14/22 | 157.62k | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 87.00 | 88.78 | 86.02 | 87.35 | 7,661,303 | 0.06 | 0.07% |
| 1 Month | 86.81 | 89.165 | 84.52 | 86.95 | 8,203,655 | 0.25 | 0.29% |
| 3 Months | 92.55 | 95.35 | 84.52 | 88.66 | 8,119,185 | -5.49 | -5.93% |
| 6 Months | 84.58 | 95.72 | 83.05 | 89.10 | 10,267,314 | 2.48 | 2.93% |
| 1 Year | 81.50 | 95.72 | 71.50 | 83.55 | 11,621,299 | 5.56 | 6.82% |
| 3 Years | 85.03 | 95.72 | 65.25 | 80.76 | 11,022,192 | 2.03 | 2.39% |
| 5 Years | 64.70 | 95.72 | 52.83 | 76.40 | 10,779,337 | 22.36 | 34.56% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
